Increased Odds for Depression and Antidepressant Use in the Inactive Spanish Population
by
, , , , and
Carmen Galán-Arroyo
1
,
Damián Pereira-Payo
2,
Jorge Rojo-Ramos
3,
Miguel A. Hernández-Mocholí
4,
Eugenio Merellano-Navarro
5,
Jorge Pérez-Gómez
2,
Ángel Denche-Zamorano
2,* and
Jose Carmelo Adsuar
1 1
Promoting a Healthy Society Research Group (PHeSO), Faculty of Sport Sciences, University of Extremadura, 10003 Caceres, Spain
2
Health Economy Motricity and Education (HEME), Faculty of Sport Science, University of Extremadura, 10003 Caceres, Spain
3
Social Impact and Innovation in Health (InHEALTH), University of Extremadura, 10003 Caceres, Spain
4
Physical Activity and Quality of Life Research Group (AFYCAV), Faculty of Sport Science, University of Extremadura, 10003 Caceres, Spain
5
Facultad de Educación, Universidad Autónoma de Chile, Talca 3460000, Chile
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(5), 2829; https://doi.org/10.3390/ijerph19052829
Submission received: 11 December 2021
/
Revised: 15 February 2022
/
Accepted: 25 February 2022
/
Published: 28 February 2022
(This article belongs to the Special Issue Feature Paper: Advance in Global Health)
Abstract
:Introduction: Depression is a disabling mental illness and therefore also a serious public health problem. It affects 5% of the adult population in the world and is the leading cause of disability, with an annual cost of USD one trillion. In Spain, its prevalence is 13.4%, costing EUR 6000 million a year. Physical inactivity has been linked to an increase in depressive symptoms, with physical activity associated with an improvement in health-related quality of life. Objective: To calculate the odds ratio (OR) and relative risk (RR) of suffering from depression and taking antidepressants in the inactive Spanish population compared to groups with a higher level of physical activity. Method: 17,141 individuals aged 18–69 years residing in Spain and interviewed in the 2017 Spanish National Health Survey were included in this cross-sectional investigation. Results: Dependence relationships were found between the level of physical activity and the prevalence of depression and taking antidepressants (p < 0.001). We found elevated ORs and RRs for depression and antidepressant use in inactive people compared to those with a high/very high level of physical activity (Depression: OR: 4.32. CI95%: 3.35–5.57. RR: 1.59. 95% CI: 1.51–1.68; Antidepressants: OR: 4.95. CI95%: 3.59–6.82. RR: 1.61. CI95%: 1.52–1.71). Conclusions: Belonging to an inactive population group increases the risk of suffering from depression and of taking antidepressants.
1. Introduction
According to the WHO, 322 million people in the world suffer from depression [1]. This mental illness presents with a disability that affects different areas of life and is associated with increased morbidity and mortality [2,3]. Depression is characterized by significant sadness, listlessness, feelings of guilt or lack of self-esteem, sleep or appetite disorders, feelings of tiredness and lack of concentration over prolonged periods of time [4], and it is the leading cause of disability worldwide, costing USD one trillion in productivity annually [5]. In Spain, its prevalence is 13.4% of the population over 15 years of age (9.1% women; 4.3% men), reaching a cost of EUR 6000 million per year, according to data from the Ministry of Health in 2018. In addition, productivity losses due to work and premature sick leave represent 67% of the total cost of depression in Spain (White Paper on Depression and Suicide 2018). Therefore, it is at minimum a significant public health problem, if not also a social and economic problem [5].
Different strategies are being carried out to decrease the costs of depression, because antidepressants, in addition to being expensive, are increasingly ineffective [6] and physical activity (PA) is being presented as a simple and effective alternative proposal [7]. In this sense, physical inactivity is associated with an increased risk of chronic disease and premature death [8], and sedentary behavior (SB) may be a risk factor for depression [9]. It appears that low physical performance is a predictor of future onset of depression in older adults [10,11]. Almost one third of the world′s population is inactive [12]. Five percent of the world′s population dies due to physical inactivity [13], which is a risk factor for diseases such as cancers, obesity, diabetes, hypertension, Alzheimer′s disease, depression, etc. [14]. Four out of ten Spaniards declare themselves sedentary [13]. This is a cause for concern.
According to the latest meta-analyses, a correlation between PA and improved health and quality of life can be observed [15]. Moreover, PA has a strong influence on the well-being of the individual [16]. It may decrease depression and, as a result, medication intake [17,18]. PA has also been found to protect against the onset of depression regardless of age and geography [19,20]. It may be a prevention and/or treatment strategy for depression [21,22].
At this point, the aim of our study is to calculate the odds ratio (OR) and relative risk of suffering from depression and taking antidepressants in the Spanish inactive population versus groups with a higher level of physical activity. The hypothesis was that physical inactivity increases the risk of suffering from depression and taking antidepressants in the Spanish population.
2. Materials and Methods
2.1. Study Design
Based on data obtained from public files provided by the Spanish Ministry of Health, Consumer Affairs and Social Welfare (MSCBS), referring to the 2017 Spanish National Health Survey (ENSE 2017), adult questionnaire (Ministry of Health, 2017), this research consisted of a cross-sectional survey-based study.
The ENSE is a survey elaborated every 5 years by the MSCBS in collaboration with the Spanish National Institute of Statistics (INE), which collects information on the health status of the population residing in Spain over 15 years of age. The surveys were conducted during the period between October 2016 and October 2017 and were carried out by qualified, previously trained interviewers.
2.2. Participants
The ENSE 2017 had a participation of 23,089 people over 15 years of age who are residents in Spain. This sample was configured based on a random three-phase sampling system.
Of the 23,089 people who participated in the ENSE 2017, only 17,141 were taken into account. The inclusion criteria were persons of legal age in Spain who presented all the data of the study variables, namely, PA variables (Q.113–Q.117), self-perceived health (G.21), variables referring to depression (G.25.1 and G.25.c) and variables referring to taking medication and antidepressants (Q.85, q86, Q.87.a and Q.87.c). Therefore, subjects under 18 years of age were excluded, as they are considered minors in Spain. Those over 70 years of age were also excluded, as the 2017 NSS did not ask such persons about PA performed. Persons who answered “Don′t know/No answer” (NS/NC) to the items mentioned above in the inclusion criteria were also excluded.
2.3. Ethics
Due to the characteristics of the research and given that the data were obtained from non-confidential open-access public files published by the MSCBS, the supervision and authorization of any official ethics committee was not necessary.
Regulation (EU) 2016/679 of the European Parliament and Council of 27 April 2016 on the protection of natural persons does not consider this type of public file as likely to be confidential. The data is presented in encrypted form, and therefore respects the anonymity of the participants.
2.4. Variables and Procedures
This research required the following questions: sex, age, G21 (Self-perceived health: In the last twelve months, would you say that your state of health has been: very good, good, fair, bad, very bad?), G25_20a (Depression: Do you suffer or have you ever suffered from depression?), G25_20c (Diagnosis of depression: Has a doctor told you that you suffer from it?), Q85 (Prescribed medications: During the past 2 weeks, have you taken any medications that were prescribed by a doctor?), Q86 (Non-prescribed medications: During the past 2 weeks, have you taken any medications, including herbal medications or vitamins, that were not prescribed by a doctor?), Q87_14a (Antidepressants: Next, I am going to read you a list of types of medications, please tell me which one(s) you have taken in the last 2 weeks: antidepressants, stimulants?), Q87_14c (Prescribed antidepressants: Prescribed by a doctor?), Q113 (Intense PA: how many days did you do intense PA?), Q114 (Duration Intense PA: How much time did you spend in total on intense PA?), Q115 (Moderate PA: How many days did you perform moderate PA?), Q116 (Duration Moderate PA: How much time did you spend in total on moderate PA?), Q117 (Walking: Now think about the time you spent walking in the last 7 days) from the ENSE 2017.
With the data obtained in the previous items of the ENSE 2017, the participants were grouped by:
Sex (Men; Women).
Age (Youth (18–34 years); Young adults (35–49 years); Older adults (50–64 years); Older (65–69 years) [23]).
Depression (Depression (Responded “Yes” to questions: Q.25_20a and Q.25_20c). No Depression (If they answered “Yes” to questions: Q.25_20a (“No”), or Q.25_20a (“Yes”) with Q.25_20c (“No”)).
Antidepressants (Antidepressants (If Q.87_14a (“Yes”). No Antidepressants (If Q.87_14a (“No”), or with Q.87_14a (No data) with Q.85 and Q.86 (“No”)).
Self-perceived health (Negative (Responded to G.21: Bad or very bad). Fair (Responded to G21: “Fair”). Positive (G21: “Good” or “Very good”)).
Level of physical activity (NAF) (To the answers given to the questions: Q.113, Q.114, Q.115 and Q.116 of the International Physical Activity Questionnaire (Craig et al., 2003), some factors were applied, adapting the Physical Activity Index [24]).
Intense intensity factor (Fii). A factor of 10 was applied to question P.113, because it is intense PA [24].
Intense frequency factor (Ffi). Factors 0 (No day a week), 1 (One day a week), 2 (Two or three days a week) and 3 (More than three days a week) were applied to the answers given to Q.113 [24].
Factor intense duration (Fdi): Factors 1 (Less than 30 min) and 1.5 (30 or more minutes) were applied to the answers given to Q.114 [24].
Factor moderate intensity (Fim): Factor 5 was applied to question P.115, for moderate PA [24].
Moderate frequency factor (Ffm): Factors 0 (No day per week), 1 (One day per week), 2 (Two or three days per week) and 3 (More than three days per week) were applied to the answers given to Q.115 [24].
Moderate duration factor (Fdm): Factors 1 (Less than 30 min) and 1.5 (30 or more minutes) were applied to the answers given to Q.116 [24].
IAF = (Fii × Ffi × Fdi) + (Fim × Ffm × Fdm).
The IAF could take values from 0 to 67.5 depending on the PA performed. Subsequently, the IAF percentiles obtained from the population were calculated and grouped by NAF: High/Very High (IAF > 30, corresponding to people in a population percentile above the 90th percentile of the IAF); Low/Medium (IAF between 1 and 30, corresponding to a value less than or equal to the 90th percentile of the population′s IAF); Walkers (FWI = 0; responded to question Q.117 that they walked at least one day a week for more than 10 min or more in a row); and Inactive (Individuals with FWI = 0; responded “No day more than 10 min in a row” to Q.117.
2.5. Statistical Analysis
The normality of the data of the variables of interest was studied with a Kolgomorov–Smirnov test without finding sufficient evidence to assume normality. Therefore, in the descriptive analysis, to characterize the sample, the data were presented through the median and interquartile range (Continuous variable: Age) and absolute and relative frequencies (Categorical variables: Age group, Depression, Antidepressants, Self-perceived health and PA level). Non-parametric statistical tests were performed, analyzing possible differences between the sexes through the Mann–Whitney U test (Age), and dependency relationships between the categorical variables of interest were analyzed through the chi-square statistic, checking for possible differences between proportions with a pairwise z test for independent proportions and using the Bonferroni correction when necessary. Odds ratios (OR) and relative risks (RR) of perceiving negative health, suffering from depression and taking antidepressants were calculated according to the different groupings of ordinal variables. A correlation study was carried out calculating Spearman′s rho. For all this, a significance level of less than 0.05 was established. The IBM SPSS Statistics v.25 computer program was used for all these analyses.
3. Results
No significant differences were found between men and women with regard to the medians presented (p = 0.506), which were 47 years both in the general population and in both sexes. Neither were dependency relationships found between sex and age groups (p = 0.242): the age groups between 35–49 and 50–64 years were those with the highest representation in both sexes (Table 1).
A total of 9.2% of the population reported having been diagnosed with depression, and significant differences were found (p < 0.05) between the proportions of men (5.9) and women (12.2). Another finding was the existence of dependency relationships between the prevalence of depression and sex (p < 0.001). Similarly, significant differences were found (p < 0.05) between the proportions of antidepressant use in men (3.3) and women (7.6), with an overall prevalence of 5.6% of antidepressant use in the population. A relationship of dependence between sex and antidepressant use was also found (p < 0.001). On the other hand, dependency relationships were found between sex on the one hand and self-perceived health (p < 0.001) and PA levels (p < 0.001) on the other (Table 1).
The self-perceived health status of the general Spanish population presented dependency relationships with the condition of having been, or not having been, diagnosed with depression (p < 0.001). Differences were found in the prevalence of the different self-perceived health states in persons with and without a diagnosis of depression (p < 0.05). Seventy-eight percent of the population not diagnosed with depression assumed positive health, compared to 28.1% in those diagnosed with depression. In contrast, the states of fair and negative presented a higher prevalence in people with depression (42.8% and 29.1%) than in those not diagnosed (17.6% and 4.5%). The same dependency relationships were found in all PA level groups (p < 0.001). Likewise, significant differences were found between the prevalence of the different self-perceived health states between depressives and non-depressives (p < 0.05). In depressives, a higher prevalence of positive health was found in those with the highest levels of PA (around 37% in the Low/Medium and High/Very High categories), and the lowest prevalence was found in inactive persons (17.5%), with differences of up to 20 percentage points and reaching up to 30 percentage points in the prevalence of negative health between the inactive (45.6%) and high/very high (13%) levels. The same trend was found in non-depressives (Table 2).
Dependency relationships were found between the prevalence of depression and age group in the general Spanish population, as well as in men and women (p < 0.001). (Table 3). In men, significant differences (p < 0.05) were found between the proportions of depressives among young people (2.7%), young adults (4.8%) and older adults (7.7% and 9.2%, respectively), with 6.5 proportional points between young men and older men. In women, differences (p < 0.05) were found between the proportions of all age groups, with a difference of 17.6 percentage points between young women and older women. These differences in intergroup proportions were also found in the general population (p < 0.05). Similarly, there were also dependency relationships between age group and the prevalence of taking antidepressants, both in the general population and in men and women (p < 0.001). In men, differences in proportions (p < 0.05) were found between youth (1.4%) and young adults (2.9%), and between both groups and older adults (4.5%) and seniors (4.3%), a difference of up to 3 percentage points. In women, these differences were found between the proportions of all age groups (p < 0.05), going from 2.2% in young women to 14.7% in older women, a difference of more than 12 percentage points. The same was found in the general population, with statistically significant differences in proportions between all age groups (p < 0.05) (Table 3).
The prevalence of depression also showed dependence relationships with PA level, both in the general population and in men and women (p < 0.001). In men, the prevalence of depression was 10.2% in inactive persons, presenting differences in proportions with the rest of the PA level groups (p < 0.05), with lower proportions with increasing PA level. These proportions were lowest in the high/very high PA group (2.7%), with a difference of 7.5 percentage points between both groups. In women, the prevalence of depression was lower in the higher PA level groups, being 5.6% in women with high/very high PA levels, 8.4% in the low/medium levels and 13.5% and 17.9% in walkers and inactive persons, respectively (p < 0.05), a difference of up to 12.3 percentage points. These intergroup differences were also found in the general population (p < 0.05). Furthermore, dependency relationships were found between the level of PA and the prevalence of antidepressant use in the general population and in both sexes (p < 0.001). Differences in depression prevalence proportions were found between inactive persons (6.7%) and walkers (3.8%), and between these groups and those with higher levels of PA (2.0% and 1.7% in the low/medium and high/very high levels) among men (p < 0.05). The same intergroup differences were found in women (p < 0.05), with a prevalence of 13.1% in inactive persons, 8.2% in walkers and a prevalence of 4.7% and 3.2% in those with low/medium and high/very high levels of PA, respectively. In the general population, differences were found between the proportions of the four PA level groups (p < 0.05) (Table 4).
In the general population, as well as in all age groups, dependency relationships were also found between the prevalence of depression and PA level (p < 0.001). In young people, no differences in proportions were found between the inactive (5.5%), walking (4.6%) and low/medium PA level (3.3%) groups, although they were found between these levels and the high/very high level (1.1%) (p < 0.05). In the rest of the age groups, differences were found between inactive persons and walkers, and between these and those at higher levels (p < 0.05). In the elderly, the differences in proportions reached 16.3 percentage points, the greatest difference in all age groups. When analyzing the relationships between the level of PA and the prevalence of taking antidepressants, dependence relationships were also found in the general population and in all age groups (p < 0.001). In young people, differences were found between the proportions of inactive persons and those with the other remaining PA levels (p < 0.05). In young adults, differences in proportions were found between all age groups, going from a prevalence of 7.8% in inactive persons to 1.2% in those with a high/very high PA level (p < 0.05) (Table 5).
Increased OR and RR of perceiving a negative state of health were found in people with depression versus non-depressives (OR: 8.80. CI: 7.10–10.05; RR: 6.53. CI: 5.87–7.26) and in people who took antidepressants versus those who did not (OR: 9.92. CI: 8.53–11.54. RR: 6.84. CI: 6.12–7.63). There were direct positive correlations between depression and negative health (rho: 0.284. p < 0.001), and between depression and taking antidepressants (rho: 0.271. p < 0.001). We also found increased OR and RR of suffering from depression (OR: 2.21 and RR: 2.07. p < 0.05) and taking antidepressants (OR: 1.86 and RR: 1.74. p < 0.05) in women compared to men (Table 6).
The older age group (elderly) also presented increased OR and RR of suffering from depression compared to the other age groups: young people (OR: 5.14. RR: 2.25), young adults (OR: 2.62. RR: 1.98) and older adults (OR: 1.32. RR: 1.24), all with a significance level of less than 0.05. Similarly, increased odds ratios and relative risks of taking antidepressants appeared in elderly vs. young (OR: 5.95. RR: 2.29), young adults (OR: 2.59. RR: 1.95) and older adults (OR: 1.28. RR: 1.21), with a significance level less than 0.05.
In relation to PA, the inactive persons presented increased risks of depression vs. walkers (OR: 1.39. RR: 1.28) and those low/medium PA levels (OR: 2.50. RR: 1.68) and high/very high PA levels (OR: 4.52. RR: 1.59), with a significance level less than 0.05. Direct correlations were also found between physical inactivity and the prevalence of depression (rho: 0.118. p < 0.001) in the inactive and high/very high PA level groups. There were similar findings for the prevalence of taking antidepressants, with increased risks in inactive persons vs. walkers (OR: 1.67. RR: 1.45) and those with low/medium PA levels (OR: 3.23. RR: 1.86) and high/very high PA levels (OR: 4.95. RR: 1.61), with p < 0.05 (Table 6).
4. Discussion
The study involved 17,141 people from the 2017 ENSE files, of whom 8942 were women and 8199 were men.
According to sex, significant differences (p < 0.05) were found between the proportions of men (5.9) and women (12.2), with a gap of 6.3 percentage points between the sexes. This is in line with the majority of studies indicating that the proportion of depression is higher in women than in men [25,26,27]. Another finding was the existence of dependency relationships between the prevalence of depression and sex (p < 0.001), as in the study by Pastor et al. where being female, among other factors, was found to be significantly associated with the risk of depression [28].
Similarly, significant differences (p < 0.05) were found between the proportions of antidepressant intake among men (3.3) and women (7.6), presenting a gap of 4.3 percentage points between the sexes, in line with the Campo-Barrientos study in which antidepressant consumption was found to be higher in women than in men [29], as well as the study of psychotropic drug consumption in Andalusia, where the prevalence of antidepressant consumption was found to be twice as high in women as in men [30]. Moreover, a dependence relationship was found between sex and antidepressant intake (p < 0.001), as in the study by Gil-García in which women were found to be three times more likely to consume antidepressants [30].
Seventy-eight percent of the population not diagnosed with depression presented positive self-perceived health, compared to 28.1% in those diagnosed with depression. This is in line with the results of another study, which concluded that those who perceive that they have a very good state of health have the lowest percentage of depression [31].
In contrast, the states of fair and negative reached higher prevalences in people with depression (42.8% and 29.1%) than in those not diagnosed (17.6% and 4.5%), with differences close to 25 percentage points, respectively. This is in line with the results of a study by Portellano-Ortiz, in which depressives showed poor perception of physical health [26].
Furthermore, significant differences were found between the prevalence of the different states of self-perceived health. In depressives, a higher prevalence of positive health was found in those with the highest levels of PA, and the lowest in inactive persons, with differences of up to 20 percentage points. The same trend was found in non-depressives. This is in line with the resuls of a study of patients with osteoarthritis [32], where self-perceived health was higher in active patients, or those of another study of young university students, where it was concluded that those with a higher level of PA had higher levels of self-perceived physical health [33].
The older age group (elderly) also presented increased OR and RR of suffering from depression, compared to the rest of the age groups. There is strong evidence in the scientific literature of a relationship between older age and higher levels of depression [34,35,36]. Similarly, increased odds ratios and relative risks of taking antidepressants appeared in older versus younger people (OR: 5.95): young (OR: 5.95. RR: 2.29), young adults (OR: 2.59. RR: 1.95) and older adults (OR: 1.28. RR: 1.21), which is in line with the results of the Henares-Montiel study [37].
The main finding concerned the relation to PA: inactive persons presented increased risks of depression vs. walkers (OR: 1.39. RR: 1.28), those with low/medium PA levels (OR: 2.50. RR: 1.68) and those with high/very high PA levels (OR: 4.52. RR: 1.59). Direct correlations were also found between physical inactivity and the prevalence of depression (rho: 0.118. p < 0.001). Similarly, in a study of patients with heart disease [38], a significant relationship was found between depression and physical inactivity. Similar results also occurred in the prevalence of taking antidepressants, with increased risks in inactive persons vs. walkers (OR: 1.67. RR: 1.45), those with low/medium PA levels (OR: 3.23. RR: 1.86) and those with high/very high PA levels (OR: 4.95. RR: 1.61), with p < 0.05. This is in line with the results of a previous study in which the probability of antidepressant intake was found to increase with inactivity [38].
4.1. Limitations
It should be noted that it there are a number of limitations to our study, such as those inherent to a survey: its cross-sectional nature and the fact that the data were obtained through information reported by the participants.
Cause–effect relationships cannot be established due to the methodology used in the article.
Only male and female sex were considered; non-binary sex was not taken into account.
Measures of physical activity were not evaluated objectively.
The diagnosis of depression was self-reported by the person participating in the study.
Only whether the participants were taking antidepressants was recorded; neither the active ingredient nor the amount taken by each participant who reported taking antidepressants was recorded.
The level of physical activity of people over 69 years of age was not recorded; no results were therefore obtained for people over 69 years of age.
4.2. Practical Implications
Possible initiatives that could be carried out through public health policies could be: the promotion of physical activity from primary care centers and through the inclusion of physical exercise professionals within the health service and in prevention services of public administrations, as well as creating programs that promote health-enhancing physical activity (HEPA) in mental health centers including multidisciplinary work by the exercise professional.
4.3. Future Lines of Research
Research with other types of designs that can establish cause and effect relationships, as well as provide information on optimal doses of PA to reduce the prevalence of depression and the use of antidepressants in the population may be useful. Moreover, comparing how the relationships found in this research have evolved during the pandemic and in future post-pandemic periods may also be a fruitful avenue for research.
5. Conclusions
It can be concluded that belonging to an inactive population group increases the risk of suffering from depression and of taking antidepressants. Walking could reduce the prevalence of depression in inactive people, although it would be advisable to incorporate programs of moderate and/or intense physical activity for a greater reduction in the prevalence of depression in the Spanish population.
Author Contributions
Conceptualization, C.G.-A., D.P.-P., J.R.-R., Á.D.-Z. and J.C.A.; formal analysis, C.G.-A., D.P.-P., J.R.-R., M.A.H.-M. and Á.D.-Z.; funding acquisition, E.M.-N.; methodology, C.G.-A., M.A.H.-M., Á.D.-Z. and J.C.A.; project administration, C.G.-A.; supervision, M.A.H.-M., E.M.-N., J.P.-G. and J.C.A.; writing—original draft, C.G.-A., D.P.-P., J.R.-R. and Á.D.-Z.; writing—review and editing, C.G.-A., J.R.-R., M.A.H.-M., E.M.-N., J.P.-G., Á.D.-Z. and J.C.A. All authors have read and agreed to the published version of the manuscript.
Funding
Proyecto 4IE + (0499_4IE_PLUS_4_E); Programa Interreg VA España-Portugal (POCTEP) 2014–2020: 0499_4IE_PLUS_4_E; Desarrollo del Observatorio El Ejercicio Te Cuida (02/03/2021–01/03/2023). Á.D.-Z. (FPU20/04201) was supported by a grant from the Spanish Ministry of Education, Culture, and Sport. Grants FPU20/04201 were funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by the “European Social Found Investing in your future” or by “European Union NextGenerationEU/PRTR”.
Institutional Review Board Statement
Due to the characteristics of the research and given that the data were obtained from non-confidential open-access public files published by the MSCBS, the supervision and authorization of any official ethics committee was not necessary.
Informed Consent Statement
The ENSE questionnaires include a legal clause informing respondents of the protection afforded to the data collected.
Data Availability Statement
The data used were obtained from public use files, which are available on the website of the Spanish Ministry of Health, Consumer Affairs, and Social Welfare: https://www.sanidad.gob.es/estadEstudios/estadisticas/EncuestaEuropea/Enc_Eur_Salud_en_Esp_2020.htm (accessed on 5 November 2021).
Acknowledgments
This article was made possible thanks to the project “Observatorio El Ejercicio Te Cuida” signed between the Fundación Jóvenes y Deporte de la Junta de Extremadura and the University of Extremadura.
Conflicts of Interest
The authors declare no conflict of interest.
References
- WHO. Depression and Other Common Mental Disorders; Global Health Estimates; WHO: Geneva, Switzerland, 2017. [Google Scholar]
- Bishwajit, G.; O’Leary, D.P.; Ghosh, S.; Yaya, S.; Shangfeng, T.; Feng, Z. Physical inactivity and self-reported depression among middle-and older-aged population in South Asia: World health survey. BMC Geriatr. 2017, 17, 1–8. [Google Scholar] [CrossRef]
- Lee, S.; McClain, C.; Webster, N.; Han, S. Question order sensitivity of subjective well-being measures: Focus on life satisfaction, self-rated health, and subjective life expectancy in survey instruments. Qual. Life Res. 2016, 25, 2497–2510. [Google Scholar] [CrossRef] [PubMed]
- WHO. The European Mental Health Action Plan 2013–2020; WHO Regional Office for Europe: Copenhagen, Denmark, 2015. [Google Scholar]
- Torres de Galvis, Y. Costos asociados con la salud mental. Rev. Cienc. Salud 2018, 16, 182–187. [Google Scholar]
- Caballero Alonso, M.S.; Franco Torres, V.J.; Marchán Cárdenas, J.C.; Montagut Vargas, A.J. Depresión Resistente al Tratamiento: Un Concepto Disgregado y el más Infortunado Diagnóstico Evolutivo de la Depresión Mayor; Medicine Degree Work, Universidad del Norte Institutional Repository: Barranquilla, Colombia, 2020. [Google Scholar]
- Calvó, F.E.J.D. PreD: Prevenir depresión, un programa de educación en salud mental. Tesis de maestría en psicología clínica y de la salud y terapias cognitivo-conductuales. Difusiones 2020, 19, 10–28. [Google Scholar]
- Villafañe, A.L.P. Estimado de la proporción Del Gasto Directo en la utilización de Servicios de Salud en Puerto Rico Para el Año 2013 Atribuible a la Inactividad física en Adultos de 18 a 64 años Con Enfermedades Crónicas No Transmisibles Asociadas a La Inactividad Física Como Factor De Riesgo. Ph.D. Thesis, University of Puerto Rico Medical Sciences, San Juan, PR, USA, 2020. [Google Scholar]
- Vancampfort, D.; Hallgre, M.; Schuch, F.; Stubbs, B.; Smith, L.; Rosebaum, S.; Firth, J.; van Dame, T.; Koyanagi, A. Sedentary behavior and depression among community-dwelling adults aged ≥ 50 years: Results from the irish longitudinal study on ageing. J. Affect. Disord. 2020, 262, 389–396. [Google Scholar] [CrossRef] [PubMed]
- Ganasarajah, S.; Sundström Poromaa, I.; Thu, W.P.P.; Kramer, M.S.; Logan, S.; Caley, J.A.; Yong, E.-L. Objective measures of physical performance associated with depression and/or anxiety in midlife Singaporean women. Menopause 2019, 26, 1045–1051. [Google Scholar] [CrossRef]
- Soysal, P.; Veronese, N.; Thompson, T.; Hahl, K.G.; Fernandes, B.S.; Prina, A.M.; Solmi, M.; Schofield, P.; Koyanagi, A.; Tseng, P.-T.; et al. Relationship between depression and frailty in older adults: A systematic review and meta-analysis. Ageing Res. Rev. 2017, 36, 78–87. [Google Scholar] [CrossRef] [Green Version]
- Rodulfo, J. Sedentarismo, la enfermedad del siglo XXI. Clin. Investig. Arterioscler. 2019, 31, 233–240. [Google Scholar]
- Rico, C.D. Inactividad física y sedentarismo en la población española. Rev. Investig. Educ. Cienc. Salud 2017, 2, 41–48. [Google Scholar]
- Martínez Rosales, F.J.; Barrera, R.V. Depresión y Control Metabólico en Pacientes de Control Rutinario por Diabetes Mellitus Tipo 2. Hospital de 4to Nivel de Barranquilla. Abril de 2016-Abril de 2017; Universitad Libre de Baranquilla: Baranquilla, Colombia, 2017. [Google Scholar]
- Aranda, R.M. Actividad física y calidad de vida en el adulto mayor. Una revisión narrativa. Rev. Habanera Cienc. Med. 2018, 17, 813–825. [Google Scholar]
- Toro Tobar, R.A.; Avendaño-Prieto, B.L.; Vargas Espinosa, N.M. Transdiagnostic model of anxiety and depression according to the relationship with affect, intolerance of uncertainly, and anxiety sensitivity. CES Psicol. 2020, 13, 140–152. [Google Scholar] [CrossRef]
- Salazar, C.F.D.; Aguliera, E.T.M.; Bolivar, L.A.R.; Parra, W.A.V. Efectos del ejercicio físico sobre la depresión y la ansiedad. Rev. Colomb. Rehabil. 2019, 18, 128–145. [Google Scholar] [CrossRef] [Green Version]
- Ivars López, E. Evidencia Bibliográfica Del Ejercicio Físico En Personas Con Depresión: Revisión Bibliográfica; Universidad Miguel Hernández: Elche, Spain, 2021. [Google Scholar]
- Hiles, S.; Lamers, F.; Milaneschi, Y.; Penninx, B.W.J.H. Sit, step, sweat: Longitudinal associations between physical activity patterns, anxiety and depression. Psychol. Med. 2017, 47, 1466–1477. [Google Scholar] [CrossRef] [PubMed]
- Schuch, F.B.; Vancampfort, D.; Firth, J.; Rosenbaum, S.; Ward, P.B.; Silva, E.S.; Hallgren, M.; De Leon, A.P.; Dunn, A.L.; Deslandes, A.C.; et al. Physical activity and incident depression: A meta-analysis of prospective cohort studies. Am. J. Psychiatry 2018, 175, 631–648. [Google Scholar] [CrossRef] [PubMed]
- Farioli-Vecchioli, S.; Sacchetti, S.; di Robilant, N.V.; Cutuli, D. The role of physical exercise and omega-3 fatty acids in depressive illness in the elderly. Curr. Neuropharmacol. 2018, 16, 308–326. [Google Scholar] [CrossRef]
- Sakurai, H.; Uchida, H.; Kato, M.; Suzuki, T.; Baba, H.; Watanabe, K.; Inada, K.; Kikuchi, T.; Katsuki, A.; Kishida, I.; et al. Pharmacological management of depression: Japanese expert consensus. J. Affect. Disord. 2020, 266, 626–632. [Google Scholar] [CrossRef]
- Tenforde, M.W.; Kim, S.S.; Lindsell, C.J.; Rose, E.B.; Shapiro, N.I.; Files, D.C.; Gibbs, K.W.; Erickson, H.L.; Steinngrub, J.S.; Smithline, H.A.; et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. Morb. Mortal. Wkly. Rep. 2020, 69, 993. [Google Scholar] [CrossRef]
- Nes, B.M.; Janszky, I.; Vatten, L.J.; Nilsen, T.I.; Aspenes, S.T.; Wisløff, U. Estimating VO 2peak from a nonexercise prediction model: The HUNT study, Norway. Med. Sci. Sports Exerc. 2011, 43, 2024–2030. [Google Scholar] [CrossRef]
- Calderón, D. Epidemiología de la depresión en el adulto mayor. Rev. Med. Herediana 2018, 29, 182–191. [Google Scholar] [CrossRef]
- Portellano-Ortiz, C.; Garre-Olmo, J.; Calvó-Perxas, L.; Conde-Sala, J.L. Depresión y variables asociadas en personas mayores de 50 años en España. Rev. Psiquiatr. Salud Ment. 2018, 11, 216–226. [Google Scholar] [CrossRef] [Green Version]
- Mera, M.A.; Morales, S.C.; García, M.R.V. Intervention with physical-recreational activity to anxiety and depression in the elderly. Rev. Cuba. Investig. Biomed. 2018, 37, 47–56. [Google Scholar]
- Pastor, I.G.; Rico, J.A.Q.; Pastor, A.G.; García, R.N.; Munuera, M.C.C. Depresión, ansiedad y salud autopercibida en estudiantes de Medicina: Un estudio transversal. Rev. Esp. Educ. Méd. 2021, 2, 21–31. [Google Scholar] [CrossRef]
- Campo Barrientos, P.D. Perfil Epidemiológico de los Consumidores de Antidepresivos en España, ens 2014. 10 November 2016. Available online: https://eprints.ucm.es/id/eprint/51082/1/PAULA%20DEL%20CAMPO%20BARRIENTOS.pdf (accessed on 10 November 2021).
- Gil-García, E.; Matos, R.C.; Claudel, B.N.; Zambrano, A.G.; Vázquez-Santiago, S.; León, A.C.; Avilés, N.R. Consumo de psicofármacos en Andalucía. Un análisis de la Encuesta Andaluza de Salud desde la perspectiva de género. Rev. Esp. Drogodepend. 2020, 45, 52–68. [Google Scholar]
- Molés Julio, M.P.; Esteve Clavero, A.; Lucas Miralles, M.V.; Folch Ayora, A. Factores asociados a la depresión en personas mayores de 75 años de edad en un área urbana. Enferm. Global. 2019, 18, 58–82. [Google Scholar] [CrossRef] [Green Version]
- Jiménez, C.L.V.; Hidalgo, J.L.T.; Atienza, E.M.G.; Ruiz, M.S.N.; Cerón, I.H.; de la Rosa, L.M. Situación funcional, autopercepción de salud y nivel de actividad física en pacientes con artrosis. Aten. Primaria 2017, 49, 224–232. [Google Scholar] [CrossRef] [Green Version]
- Domingo Orduña, C. Nivel de Actividad Física Diaria y Relación con la Salud de Jóvenes Universitarios; Universidad de Jaén: Jaen, Spain, 2021. [Google Scholar]
- Luppa, M.; Sikorski, C.; Luck, T.; Ehreke, L.; Konnopka, A.; Wiese, B.; Weyerer, S.; Konig, H.; Riedel-Heller, S.G. Age-and gender-specific prevalence of depression in latest-life–systematic review and meta-analysis. J. Affect. Disord. 2012, 136, 212–221. [Google Scholar] [CrossRef]
- Iden, K.R.; Engedal, K.; Hjorleifsson, S.; Ruths, S. Prevalence of depression among recently admitted long-term care patients in Norwegian nursing homes: Associations with diagnostic workup and use of antidepressants. Dement. Geriatr. Cogn. Disord. 2014, 37, 154–162. [Google Scholar] [CrossRef] [Green Version]
- Cardos, Y.A.; Teruel, S.B.; Revert, B.A.; Belmonte, S.P.; Germes, A.O.; Llinares, L. El Papel de la Depresión en la Predicción de la Calidad de Vida de las Personas Mayores; Universidad Internacional de Valencia: Valencia, Spain, 2020; p. 5. [Google Scholar]
- Henares Montiel, J.; Ruiz-Pérez, I.; Sordo, L.J.G.S. Salud mental en España y diferencias por sexo y por comunidades autónomas. Gac. Sanit. 2020, 34, 114–119. [Google Scholar] [CrossRef]
- Paucara Pfoccori, M. Inactividad Física Asociado a Depresión y Ansiedad en Pacientes con Enfermedades Cardiovasculares que Asisten a Consulta Externa de Cardiología del Hospital III Goyeneche, Febrero 2020; Universidad Nacional de San Agustín de Arequipa: Arequipa, Peru, 2020. [Google Scholar]
Table 1.
Sociodemographic characteristics, prevalence of depression, use of antidepressants and level of physical activity in the Spanish population aged 18–69 years in 2017.
Table 1.
Sociodemographic characteristics, prevalence of depression, use of antidepressants and level of physical activity in the Spanish population aged 18–69 years in 2017.
| Variables | ||||
|---|---|---|---|---|
| Age (Years) | Total = 17141 | Men = 8199 | Women = 8942 | p |
| Median (RI) | 47 (21) | 47 (20) | 47 (21) | 0.506 |
| Mean (SD) | 46.8 (13.3) | 46.8 (13.2) | 46.9 (13.3) | - |
| Age group (Years) | Total n (%) | Men n (%) | Women n (%) | p * |
| 18–34 | 3297 (19.2) | 1562 (19.1) | 1735 (19.4) | 0.242 |
| 35–49 | 6177 (36.0) | 2993 (36.5) | 3184 (35.6) | |
| 50–64 | 5956 (34.7) | 2860 (34.9) | 3096 (34.6) | |
| 65–69 | 1711 (10.0) | 784 (9.6) | 927(10.4) | |
| Depression | Total = 17137 | Men = 8198 | Women = 8939 | p * |
| Yes n (%) | 1572 (9.2) | 480 (5.9) a | 1092 (12.2) b | <0.001 |
| No n (%) | 15565 (90.8) | 7718 (94.1) a | 7847 (87.8) b | |
| Antidepressants | Total = 17138 | Men = 8198 | Women = 8940 | p * |
| Yes n (%) | 954 (5.6) | 273 (3.3) a | 681 (7.6) b | <0.001 |
| No n (%) | 16184 (94.4) | 7925 (96.7) a | 8259 (92.4) b | |
| Self-perceived health | Total = 17141 | Men = 8199 | Women = 8942 | p * |
| Negative | 1151 (6.7) | 486 (5.9) a | 665 (7.4) b | <0.001 |
| Regular | 3413 (19.9) | 1439 (17.6) a | 1974 (22.1) b | |
| Positive | 12577 (73.4) | 6274 (76.5) a | 6303 (70.5) b | |
| Physical Activity Level | Total n (%) | Men n (%) | Women n (%) | p * |
| Inactive | 2482 (14.5) | 1156 (14.1) | 1326 (14.8) | <0.001 |
| Walkers | 7901 (46.1) | 3335 (40.7) | 4566 (51.1) | |
| Low/Medium | 4688 (27.3) | 2350 (28.7) | 2338 (26.1) | |
| High/Very High | 2070 (12.1) | 1358 (16.6) | 712 (8.0) | |
RI (Interquartile range); SD (Standard deviation); n (Number of participants); % (Percentage); Negative (They declared their health to be bad or very bad); Regular (They declared their health as regular); Positive (They declared their health as good or very good); IAF (Physical Activity Index); Inactive (IAF = 0; People who declare not to walk more than 10 min in a row). Walkers (IAF = 0; People who report walking more than 10 min in a row); Low/Medium (IAF between 1 and 30); High/Very High (FTI > 30); p (p value from Mann–Whitney U test); p * (p-value from chi-square test); ab (Each letters corresponds to significant differences between column proportions at 95% from pairwise z-test); Depression (reported or not to have been diagnosed with depression by a physician); Antidepressants (reported or not to have consumed antidepressants or stimulants in the two weeks prior to the survey).
Table 2.
Relationship between the prevalence of depression and self-perceived health in the general Spanish population of the ENSE 2017 aged between 18 and 69 years, and according to the level of physical activity.
Table 2.
Relationship between the prevalence of depression and self-perceived health in the general Spanish population of the ENSE 2017 aged between 18 and 69 years, and according to the level of physical activity.
| Self-Perceived Health: n (%) | ||||||
|---|---|---|---|---|---|---|
| LPA | Depression | Total | Positive | Regular | Negative | p |
| Inactive (n = 2481) | Yes | 355 (14.3) | 62 (17.5) a | 131 (36.9) a | 162 (45.6) a | <0.001 |
| No | 2126 (85.7) | 1432 (67.4) b | 465 (21.9) b | 229 (10.8) b | ||
| Walkers (n = 7899) | Yes | 846 (10.7) | 242 (28.6) a | 379 (44.8) a | 225 (26.6) a | <0.001 |
| No | 7053 (89.3) | 5247 (74.4) b | 1464 (20.8) b | 342 (4.8) b | ||
| Low/Medium (n = 4687) | Yes | 294 (6.3) | 109 (37.1) a | 125 (42.5) a | 60 (20.4) a | <0.001 |
| No | 4393 (93.7) | 3681 (83.8) b | 626 (14.2) b | 86 (2.0) b | ||
| High/Very High (n = 2070) | Yes | 77 (3.7) | 29 (37.7) a | 38 (49.4) a | 10 (13.0) a | <0.001 |
| No | 1993 (96.3) | 1774 (89.0) b | 183 (9.2) b | 36 (1.8) b | ||
| Total (n = 17137) | Yes | 1572 (9.2) | 442 (28.1) a | 673 (42.8) a | 457 (29.1) a | <0.001 |
| No | 15565 (90.8) | 12134 (78.0) b | 2738 (17.6) b | 693 (4.5) b | ||
Depression (Whether or not they declared having been diagnosed with depression); n (Number of participants); % (Percentage); PAL (Physical activity level); IAF (Physical Activity Index); Inactive (IAF = 0; People who declared not going for a walk for more than 10 min at a time). Walkers (IAF = 0; People who report walking more than 10 min in a row); Low/Medium (IAF between 1 and 30); High/Very High (FWI > 30); p (p-value from chi-square test); ab (Different letters correspond to significant differences between column proportions in each NAF group and self-perceived health status at 95% from pairwise z-test).
Table 3.
Relationship between the prevalence of anxiety and age group in the general Spanish population of the 2017 ENSE aged between 18 and 64 years, and by sex.
Table 3.
Relationship between the prevalence of anxiety and age group in the general Spanish population of the 2017 ENSE aged between 18 and 64 years, and by sex.
| Age Group: n (%) | |||||||
|---|---|---|---|---|---|---|---|
| Sex | Depression | Total | 18–34 Age | 35–49 Age | 50–64 Age | 65–69 Age | p |
| Men (n = 8198) | Yes | 480 (5.9) | 42 (2.7) a | 145 (4.8) b | 221 (7.7) c | 72 (9.2) c | <0.001 |
| No | 7718 (94.1) | 1520 (97.3) a | 2847 (95.2) b | 2639 (92.3) c | 712 (90.8) c | ||
| Women (n = 8939) | Yes | 1092 (12.2) | 77 (4.4) a | 277 (8.7) b | 534 (17.3) c | 204 (22.0) d | <0.001 |
| No | 7847 (87.8) | 1657 (95.6) a | 2907 (91.3) b | 2560 (82.7) c | 723 (78.0) d | ||
| Total (n = 17137) | Yes | 1572 (9.2) | 119 (3.6) a | 422 (6.8) b | 755 (12.7) c | 276 (16.1) d | <0.001 |
| No | 15565 (90.8) | 3177 (96.4) a | 5754 (93.2) b | 5199 (33.4) c | 1435 (83.9) d | ||
| Sex | Antidepressants | Total | 18–34 Age | 35–49 Age | 50–64 Age | 65–69 Age | p |
| Men (n = 8198) | Yes | 273 (3.3) | 22 (1.4) a | 87 (2.9) b | 130 (4.5) c | 34 (4.3) c | <0.001 |
| No | 7925 (96.7) | 1540 (98.6) a | 2906 (97.1) b | 2729 (95.5) c | 750 (95.7) c | ||
| Women (n = 8940) | Yes | 681 (7.6) | 38 (2.2) a | 165 (5.2) b | 342 (11.1) c | 136 (14.7) d | <0.001 |
| No | 8259 (92.4) | 1697 (97.8) a | 3019 (94.8) b | 2752 (88.9) c | 791 (85.3) d | ||
| Total (n = 17138) | Yes | 954 (5.6) | 60 (1.8) a | 252 (4.1) b | 472 (7.9) c | 170 (9.9) d | <0.001 |
| No | 16184 (94.4) | 3237 (98.2) a | 5925 (95.9) b | 5481 (92.1) c | 1541 (90.1) d | ||
Anxiety (Whether or not they reported having been diagnosed with depression); Antidepressants (Whether or not they reported having taken antidepressants or stimulants in the two weeks prior to the survey); n (Number of participants); % (Percentage); p (p-value from chi-square test); abcd (Different letters correspond to significant differences between column proportions of the same row at 95% from pairwise z-test).
Table 4.
Relationship between the prevalence of antidepressants and the level of physical activity in the general Spanish population of the ENSE 2017 aged between 18 and 69 years, and by sex.
Table 4.
Relationship between the prevalence of antidepressants and the level of physical activity in the general Spanish population of the ENSE 2017 aged between 18 and 69 years, and by sex.
| Physical Activity Level: n (%) | |||||||
|---|---|---|---|---|---|---|---|
| Sex | Depression | Total | Inactive | Walkers | Low/ Medium | High/Very High | p |
| Men (n = 8198) | Yes | 480 (5.9) | 118 (10.2) a | 228 (6.8) b | 97 (4.1) c | 37 (2.7) d | <0.001 |
| No | 7718 (94.1) | 1038 (89.8) a | 3107 (93.2) b | 2252 (95.9) c | 1321 (97.3) d | ||
| Women (n = 8939) | Yes | 1092 (12.2) | 237 (17.9) a | 618 (13.5) b | 197 (8.4) c | 40 (5.6) d | <0.001 |
| No | 7847 (87.8) | 1088 (82.1) a | 3946 (86.5) b | 2141 (91.6) c | 672 (94.4) d | ||
| Total (n = 17137) | Yes | 1572 (9.2) | 355 (14.3) a | 846 (10.7) b | 294 (6.3) c | 77 (3.7) d | <0.001 |
| No | 15565 (90.8) | 2126 (85.7) a | 7053 (89.3) b | 4393 (93.7) c | 1993 (96.3) d | ||
| Sex | Antidepressants | Total | Inactive | Walkers | Low/Medium | High/Very High | p |
| Men (n = 8198) | Yes | 273 (3.3) | 77 (6.7) a | 126 (3.8) b | 47 (2.0) c | 23 (1.7) c | <0.001 |
| No | 7925 (96.7) | 1079 (93.3) a | 3208 (96.2) b | 2303 (98.0) c | 1335 (98.3) c | ||
| Women (n = 8940) | Yes | 681 (7.6) | 174 (13.1) a | 373 (8.2) b | 111 (4.7) c | 23 (3.2) c | <0.001 |
| No | 8259 (92.4) | 1152 (86.9) a | 4192 (91.8) b | 2226 (95.3) c | 689 (96.8) c | ||
| Total (n = 17138) | Yes | 954 (5.6) | 248 (10.1) a | 499 (6.3) b | 158 (3.4) c | 46 (2.2) d | <0.001 |
| No | 16184 (94.4) | 2231 (89.9) a | 7400 (93.7) b | 4529 (96.6) c | 2024 (97.8) d | ||
Depression (Whether or not they reported having been diagnosed with depression); Antidepressants (Whether or not they reported having taken antidepressants); n (Number of participants); % (Percentage); IAF (Physical Activity Index); Inactive (IAF = 0; People who reported not going for a walk for more than 10 min at a time). Walkers (IAF = 0; People who reported walking more than 10 min in a row); Low/Medium (IAF between 1 and 30); High/Very High (FWI > 30); p (p-value from chi-square test); abcd (Different letters correspond to significant differences between column proportions at 95% from pairwise z-test).
Table 5.
Relationship between prevalence of depression, taking antidepressants and level of physical activity, according to age group in the general Spanish population of the 2017 ENSE aged between 18 and 69 years, and by age group.
Table 5.
Relationship between prevalence of depression, taking antidepressants and level of physical activity, according to age group in the general Spanish population of the 2017 ENSE aged between 18 and 69 years, and by age group.
| Physical Activity Level: n (%) | |||||||
|---|---|---|---|---|---|---|---|
| Age | Depression | Total | Inactive | Walkers | Low/Medium | High/Very High | p |
| 18–34 years (n = 3296) | Yes | 119 (3.6) | 23 (5.5) a | 56 (4.6) a | 33 (3.3) a | 7 (1.1) b | <0.001 |
| No | 3177 (96.4) | 398 (94.5) a | 1162 (95.4) a | 975 (96.7) a | 642 (98.9) b | ||
| 35–49 years (n = 6176) | Yes | 422 (6.8) | 103 (11.0) a | 202 (7.9) b | 90 (4.9) c | 27 (3.3) c | <0.001 |
| No | 5754 (93.2) | 832 (89.0) a | 2363 (92.1) b | 1760 (95.1) c | 799 (96.7) c | ||
| 50–64 years (n = 5954) | Yes | 755 (12.7) | 173 (19.7) a | 418 (13.4) b | 126 (8.8) c | 38 (7.4) c | <0.001 |
| No | 5199 (87.3) | 704 (80.3) a | 2705 (86.6) b | 1313 (91.2) c | 477 (92.6) c | ||
| 65–69 years (n = 1711) | Yes | 276 (16.1) | 56 (22.6) a | 170 (17.1) b | 45 (11.5) c | 5 (6.3) c | <0.001 |
| No | 1435 (83.9) | 192 (77.4) a | 823 (82.9) b | 345 (88.5) c | 75 (93.8) c | ||
| Total (n = 17137) | Yes | 1572 (9.2) | 348 (13.7) a | 788 (9.8) b | 320 (6.5) c | 83 (3.7) d | <0.001 |
| No | 15565 (90.8) | 2185 (86.3) a | 7279 (90.2) b | 4567 (93.5) c | 2144 (96.3) d | ||
| Age | Antidepressant | Total | Inactive | Walkers | Low/Medium | High/Very High | p |
| 18–34 years (n = 3237) | Yes | 60 (1.8) | 20 (4.8) a | 26 (2.1) b | 8 (0.8) c | 6 (0.9) b,c | <0.001 |
| No | 3237 (98.2) | 401 (95.2) a | 1193 (97.9) b | 1000 (99.2) c | 643 (99.1) b,c | ||
| 35–49 years (n = 6177) | Yes | 252 (4.1) | 73 (7.8) a | 116 (4.5) b | 53 (2.0) c | 10 (1.2) d | <0.001 |
| No | 5925 (95.9) | 862 (92.2) a | 2449 (95.5) b | 1798 (97.1) c | 816 (98.8) d | ||
| 50–64 years (n = 5953) | Yes | 472 (7.9) | 118 (13.4) a | 259 (8.3) b | 69 (4.8) c | 26 (5.0) c | <0.001 |
| No | 5481 (92.1) | 760 (86.6) a | 2863 (91.7) b | 1369 (95.2) c | 489 (95.0) c | ||
| 65–69 years (n = 1711) | Yes | 170 (9.9) | 40 (16.1) a | 98 (9.9) b | 28 (7.2) b | 4 (5.0) b | <0.001 |
| No | 1541 (90.1) | 208 (83.9) a | 895 (90.1) b | 362 (92.8) b | 76 (95.0) b | ||
| Total (n = 17716) | Yes | 954 (5.6) | 251 (10.1) a | 499 (6.3) b | 158 (3.4) c | 46 (2.2) d | <0.001 |
| No | 16184 (94.4) | 2231 (89.9) a | 7400 (93.7) b | 4529 (96.6) c | 2024 (97.8) d | ||
Depression (Whether or not they declared having been diagnosed with depression); Antidepressants (Whether or not they declared having taken antidepressants or stimulants); n (Number of participants); % (Percentage); IAF (Physical Activity Index); Inactive (IAF = 0; People who declared not going for a walk for more than 10 min at a time). Walkers (IAF = 0; People who reported walking more than 10 min in a row); Low/Medium (IAF between 1 and 30); High/Very High (FWI > 30); p (p value from chi-square test); abcd (Different letters correspond to significant differences between column proportions at 95% from pairwise z-test).
Table 6.
In the Spanish population aged 18–69 years: Ratio of probability and relative risk of having a negative perception of health, whether or not suffering from depression, or taking antidepressants; probability and relative risks of suffering from depression and taking antidepressants, according to age group; and level of physical activity.
Table 6.
In the Spanish population aged 18–69 years: Ratio of probability and relative risk of having a negative perception of health, whether or not suffering from depression, or taking antidepressants; probability and relative risks of suffering from depression and taking antidepressants, according to age group; and level of physical activity.
| Risks of having negative self-perceived health | ||||||||
| Depression Condition | OR | CI95% | RR | CI95% | p * | rho | p | |
| Depression | No Depression | 8.80 | 7.70–10.05 | 6.53 | 5.87–7.26 | <0.001 | 0.284 | <0.001 |
| Antidepressants | No Antidepressants | 9.92 | 8.53–11.54 | 6.84 | 6.12–7.63 | <0.001 | 0.271 | <0.001 |
| Risk of depression | ||||||||
| Sex | OR | CI95% | RR | CI95% | p * | rho | p | |
| Women | Men | 2.21 | 1.97–2.47 | 2.07 | 1.86–2.29 | <0.001 | 0.106 | <0.001 |
| Age Group | OR | CI95% | RR | CI95% | p * | rho | p | |
| 65–69 years | 18–34 years | 5.14 | 4.11–6.42 | 2.25 | 2.08–2.43 | <0.001 | 0.22 | <0.001 |
| 35–49 years | 2.62 | 2.23–3.09 | 1.98 | 1.79–2.20 | <0.001 | 0.135 | <0.001 | |
| 50–64 years | 1.32 | 1.14–1.54 | 1.24 | 1.11–1.38 | <0.001 | 0.042 | <0.001 | |
| 50–64 years | 18–34 years | 3.88 | 3.18–4.73 | 1.39 | 1.35–1.44 | <0.001 | 0.120 | <0.001 |
| 35–49 years | 1.98 | 1.75–2.24 | 1.35 | 1.29–1.42 | <0.001 | 0.099 | <0.001 | |
| 35–49 years | 18–34 years | 1.96 | 1.59–2.41 | 1.21 | 1.16–1.27 | <0.001 | 0.066 | <0.001 |
| Physical Activity Level IAF Level | OR | CI95% | RR | CI95% | p * | rho | p | |
| Inactive | Walkers | 1.39 | 1.22–1.59 | 1.28 | 1.16–1.40 | <0.001 | 0.048 | <0.001 |
| Low/Medium | 2.50 | 2.12–2.94 | 1.68 | 1.55–1.81 | <0.001 | 0.133 | <0.001 | |
| High/Very High | 4.32 | 3.35–5.57 | 1.59 | 1.51–1.68 | <0.001 | 0.180 | <0.001 | |
| Walkers | Low/Medium | 1.79 | 1.56–2.06 | 1.20 | 1.16–1.25 | <0.001 | 0.075 | <0.001 |
| High/Very High | 3.11 | 2.45–3.94 | 1.18 | 1.15–1.20 | <0.001 | 0.098 | <0.001 | |
| Low/Medium | High/Very High | 1.73 | 1.34–2.24 | 1.15 | 1.10–1.22 | <0.001 | 0.052 | <0.001 |
| Risks of antidepressant use | ||||||||
| Sex | OR | CI95% | RR | CI95% | p * | rho | p | |
| Women | Men | 1.86 | 1.68–2.05 | 1.74 | 1.59–1.90 | <0.001 | 0.093 | <0.001 |
| Age Groups | OR | CI95% | RR | CI95% | p * | rho | p | |
| 65–69 years | 18–34 years | 5.95 | 4.41–8.04 | 2.29 | 2.10–2.50 | <0.001 | 0.184 | <0.001 |
| 35–49 years | 2.59 | 2.12–3.18 | 1.95 | 1.72–2.21 | <0.001 | 0.107 | <0.001 | |
| 50–64 years | 1.28 | 1.07–1.54 | 1.21 | 1.05–1.38 | <0.01 | 0.030 | <0.01 | |
| 50–64 years | 18–34 years | 4.65 | 3.54–6.10 | 1.41 | 1.36–1.46 | <0.001 | 0.126 | <0.001 |
| 35–49 years | 2.03 | 1.73–2.37 | 1.36 | 1.28–1.44 | <0.001 | 0.081 | <0.001 | |
| 35–49 years | 18–34 years | 2.30 | 1.73–3.05 | 1.25 | 1.18–1.32 | <0.001 | 0.060 | <0.001 |
| Physical Activity Level IAF Level | OR | CI95% | RR | CI95% | p * | rho | p | |
| Inactive | Walkers | 1.67 | 1.42–1.96 | 1.45 | 1.30–1.61 | <0.001 | 0.063 | <0.001 |
| Low/Medium | 3.23 | 2.63–3.96 | 1.86 | 1.71–2.02 | <0.001 | 0.138 | <0.001 | |
| High/Very High | 4.95 | 3.59–6.82 | 1.61 | 1.52–1.71 | <0.001 | 0.159 | <0.001 | |
| Walkers | Low/Medium | 1.93 | 1.61–2.32 | 1.22 | 1.17–1.28 | <0.001 | 0.064 | <0.001 |
| High/Very High | 2.97 | 2.19–4.03 | 1.17 | 1.13–1.20 | <0.001 | 0.073 | <0.001 | |
| Low/Medium | High/Very High | 1.54 | 1.10–2.14 | 1.12 | 1.04–1.21 | <0.05 | 0.031 | <0.05 |
OR (Odds ratio); CI (Confidence Interval); RR (Relative risk); PAI (Physical Activity Index); Inactive (PAI = 0; Reported not walking more than 10 min in a row); Insufficient (IAF = 0; They reported walking more than 10 min in a row); Low (IAF between 1 and 15); Medium (IAF between 16 and 30). High (FWI between 31 and 45); Very High (FWI greater than 45); p (p-value); rho (Spearman correlation coefficient); p * (p-value from chi-square test); Depression (reported having been diagnosed with depression); No depression (reported not having been diagnosed); Antidepressants (Reported taking antidepressants or stimulants); Antidepressants (Reported taking antidepressants or stimulants in the two weeks prior to the survey); No antidepressants (Reported not taking antidepressants or stimulants in the two weeks prior to the survey).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Galán-Arroyo, C.; Pereira-Payo, D.; Rojo-Ramos, J.; Hernández-Mocholí, M.A.; Merellano-Navarro, E.; Pérez-Gómez, J.; Denche-Zamorano, Á.; Adsuar, J.C. Increased Odds for Depression and Antidepressant Use in the Inactive Spanish Population. Int. J. Environ. Res. Public Health 2022, 19, 2829. https://doi.org/10.3390/ijerph19052829
AMA Style
Galán-Arroyo C, Pereira-Payo D, Rojo-Ramos J, Hernández-Mocholí MA, Merellano-Navarro E, Pérez-Gómez J, Denche-Zamorano Á, Adsuar JC. Increased Odds for Depression and Antidepressant Use in the Inactive Spanish Population. International Journal of Environmental Research and Public Health. 2022; 19(5):2829. https://doi.org/10.3390/ijerph19052829
Chicago/Turabian StyleGalán-Arroyo, Carmen, Damián Pereira-Payo, Jorge Rojo-Ramos, Miguel A. Hernández-Mocholí, Eugenio Merellano-Navarro, Jorge Pérez-Gómez, Ángel Denche-Zamorano, and Jose Carmelo Adsuar. 2022. "Increased Odds for Depression and Antidepressant Use in the Inactive Spanish Population" International Journal of Environmental Research and Public Health 19, no. 5: 2829. https://doi.org/10.3390/ijerph19052829
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
